Cellular uptake of imatinib into leukemic cells is independent of human organic cation transporter 1 (OCT1)

PURPOSE: In addition to mutated BCR-ABL1 kinase, the organic cation transporter 1 (OCT1, encoded by SLC22A1) has been considered to contribute to imatinib resistance in patients with chronic myeloid leukemia (CML). Since data are conflicting as to whether OCT1 transports imatinib and may serve as cl...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Nies, Anne T., Schaeffeler, Elke, van der Kuip, Heiko, Cascorbi, Ingolf, Bruhn, Oliver, Kneba, Michael, Pott, Christiane, Hofmann, Ute, Volk, Christopher, Hu, Shuiying, Baker, Sharyn D., Sparreboom, Alex, Ruth, Peter, Koepsell, Hermann, Schwab, Matthias
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3932302/
https://ncbi.nlm.nih.gov/pubmed/24352644
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-13-1999
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados